Single-Nucleotide Polymorphisms of ABCG2 Increase the Efficacy of Tyrosine Kinase Inhibitors in the K562 Chronic Myeloid Leukemia Cell Line
Pharmacogenetics and Genomics - United States
doi 10.1097/fpc.0000000000000022
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)